Furthermore, we found that HDAC3 but not HDAC3 R265P mutation (an inactivation mutation in HDCA3)38 overexpression decreased the proliferation and the sphere-forming ability in SCARB2-deleted HCC cells (Fig. 5j, k). This evidence concerns the gene SCARB2 and hepatocellular carcinoma.